MARKET

DGX

DGX

QuestDiagnostics
NYSE

Real-time Quotes | Nasdaq Last Sale

138.95
+0.56
+0.40%
After Hours: 138.07 -0.88 -0.63% 17:14 05/07 EDT
OPEN
138.65
PREV CLOSE
138.39
HIGH
140.64
LOW
138.65
VOLUME
1.26M
TURNOVER
--
52 WEEK HIGH
140.64
52 WEEK LOW
103.26
MARKET CAP
18.15B
P/E (TTM)
10.54
1D
5D
1M
3M
1Y
5Y
Quest Diagnostics Inc. stock rises Friday, still underperforms market
marketwatch.com · 1h ago
Stocks That Hit 52-Week Highs On Friday
    On Friday morning, 417 companies achieved new highs for the year.
Benzinga · 7h ago
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6)
Benzinga · 10h ago
Quest Diagnostics Inc. stock outperforms market on strong trading day
marketwatch.com · 1d ago
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5)
Benzinga · 1d ago
Drug Screening Market worth $10.0 billion by 2025 | Key Players are LabCorp (US), Quest Diagnostics (US)
May 05, 2021 (AB Digital via COMTEX) --  According to the new market research report "Drug Screening Market by Product (Consumables, Urine...
ABNewswire · 1d ago
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Shares of Quest Diagnostics Inc. inched 0.13% higher to $136.57 Wednesday, on what proved to be an all-around positive trading session for the stock market,...
marketwatch.com · 2d ago
Weatherly Asset Management L. P. Buys Vanguard International Dividend Appreciation ETF, NextEra ...
GuruFocus News · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DGX. Analyze the recent business situations of QuestDiagnostics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DGX stock price target is 143.60 with a high estimate of 158.00 and a low estimate of 130.00.
EPS
Institutional Holdings
Institutions: 1.09K
Institutional Holdings: 127.64M
% Owned: 97.71%
Shares Outstanding: 130.64M
TypeInstitutionsShares
Increased
283
7.60M
New
125
1.70M
Decreased
256
8.38M
Sold Out
62
1.70M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.41%
Healthcare Providers & Services
+1.36%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen Rusckowski
Chief Financial Officer/Executive Vice President
Mark Guinan
Executive Vice President
James Davis
Senior Vice President/General Counsel
Michael Prevoznik
Senior Vice President
Catherine Doherty
Senior Vice President
Carrie Manner
Lead Director/Independent Director
Daniel Stanzione
Independent Director
Vicky Gregg
Independent Director
Wright Lassiter
Independent Director
Timothy Main
Independent Director
Denise Morrison
Independent Director
Gary Pfeiffer
Independent Director
Timothy Ring
Independent Director
Helen Torley
Independent Director
Gail Wilensky
Declaration Date
Dividend Per Share
Ex-Div Date
02/04/2021
Dividend USD 0.62
04/06/2021
11/18/2020
Dividend USD 0.56
01/19/2021
08/18/2020
Dividend USD 0.56
10/05/2020
05/18/2020
Dividend USD 0.56
07/07/2020
01/30/2020
Dividend USD 0.56
04/06/2020
11/20/2019
Dividend USD 0.53
01/13/2020
08/15/2019
Dividend USD 0.53
10/03/2019
05/14/2019
Dividend USD 0.53
07/05/2019
03/01/2019
Dividend USD 0.53
04/05/2019
11/28/2018
Dividend USD 0.53
01/14/2019
08/17/2018
Dividend USD 0.5
10/04/2018
05/14/2018
Dividend USD 0.5
07/06/2018
02/01/2018
Dividend USD 0.5
04/03/2018
11/29/2017
Dividend USD 0.45
01/08/2018
08/18/2017
Dividend USD 0.45
10/02/2017
05/16/2017
Dividend USD 0.45
07/06/2017
02/21/2017
Dividend USD 0.45
04/03/2017
11/21/2016
Dividend USD 0.45
01/06/2017
08/17/2016
Dividend USD 0.4
09/30/2016
05/18/2016
Dividend USD 0.4
07/01/2016
02/02/2016
Dividend USD 0.4
04/04/2016
12/04/2015
Dividend USD 0.38
01/08/2016
08/18/2015
Dividend USD 0.38
10/02/2015
05/15/2015
Dividend USD 0.38
07/06/2015
01/29/2015
Dividend USD 0.38
04/06/2015
12/04/2014
Dividend USD 0.33
01/09/2015
08/15/2014
Dividend USD 0.33
10/03/2014
05/21/2014
Dividend USD 0.33
07/07/2014
01/30/2014
Dividend USD 0.33
04/04/2014
12/06/2013
Dividend USD 0.3
01/03/2014
08/20/2013
Dividend USD 0.3
09/27/2013
05/21/2013
Dividend USD 0.3
06/28/2013
About DGX
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.

Webull offers kinds of Quest Diagnostics Inc stock information, including NYSE:DGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DGX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DGX stock methods without spending real money on the virtual paper trading platform.